Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 541 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
BRIEF COMMUNICATION
Year : 2012  |  Volume : 16  |  Issue : 8  |  Page : 432-433

Baseline results indicate poor glycemic control and delay in initiation and optimization of insulin therapy: results from the improving management practices and clinical outcomes in type 2 diabetes study


1 Institute of Diabetology, Madras Medical College, Chennai, India
2 Dr. V. Seshiah Diabetes Research Institute and Dr. Balaji Diabetes Care Centre, Aminjikarai, Chennai, India
3 Department of Medicine, Osmania Medical College, Ameerpet, Hyderabad, India
4 Diabetes Care and Research Centre, GCIB, Patna, India
5 Department of Diabetology, Government Rajaji Medical College, Madurai, India
6 Diabetes Care and Research Institute, Aminjikarai, Chennai, India
7 Bharti Hospital and B.R.I.D.E., Karnal, India
8 Novo Nordisk India Pvt. Ltd, Bangalore, Karnataka, India
9 Department of Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry, India

Correspondence Address:
C R Anand Moses
Institute of Diabetology, 22, Casa Major Road, Egmore, Chennai - 600 008
India
Login to access the Email id

Source of Support: Unrestricted educational grant from novonordisk India Limited, Conflict of Interest: None


DOI: 10.4103/2230-8210.104120

Rights and Permissions

Introduction: Improving management practices and clinical outcomes in type 2 diabetes (IMPACT), was a prospective, open-label, 26- week, comparative, multi-center study to compare efficacy and safety of the Indian insulin guideline (IIG) group versus routine clinical practice (RCP) group in patients with type 2 diabetes. Materials and Methods: A total of 20,653 patients from 885 centers across India were enrolled and treated with premixed insulin therapy as per IIG or routine care. Results: Most of the participating centers (81.7%) reported following a diabetes guideline in their practice routinely but only 20.4% targeted HbA1c <7%. Very few of the physicians (2.7%) reported that most of their patients (>75%) achieved an HbA1c <7%. Most of the physicians (39.8%) also agreed that only 10-25% of the patients agree to start insulin therapy at the first counseling. Mean duration of diabetes before initiating insulin in patients using oral anti-diabetic drugs (OADs) was 7 years, indicating a delay in initiating insulin therapy. The difference in mean daily dose of insulin at initiation vs. at 26 weeks was only 0.8 U (25.8 ± 11.3 at initiation compared to 26.6 ± 9.5, respectively, p = ns) suggesting lack of treatment optimization. Weekly titration till achieving HbA1c <7% was done in 51.1% of the patients and only 8.9% performed self-titration. Conclusion: Baseline glycemic control in these patients was poor and reflects a delay in initiating insulin therapy. Data also reflect a lack of optimization of insulin doses.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed929    
    Printed22    
    Emailed0    
    PDF Downloaded218    
    Comments [Add]    

Recommend this journal